XML 60 R49.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Compensation Plans (Details) (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
May 31, 2013
Stock Compensation Plans [Abstract]      
Number of stock compensation plans 2    
Compensation Expense [Abstract]      
Total stock-based compensation expense $ 2,573,000 $ 1,619,000  
Tax benefit (952,000) (599,000)  
Stock-based compensation expense, net of tax 1,621,000 1,020,000  
Stock Options [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period, minimum (in years) P2Y    
Vesting period, maximum (in years) P4Y    
Compensation Expense [Abstract]      
Total stock-based compensation expense 1,212,000 1,331,000  
Valuation Assumptions [Abstract]      
Expected dividend yield, maximum (in hundredths) 1.02%    
Expected stock price volatility, minimum (in hundredths) 46.40%    
Expected stock price volatility, maximum (in hundredths) 53.00%    
Risk free interest rate, minimum (in hundredths) 0.27%    
Risk free interest rate, maximum (in hundredths) 0.60%    
Expected life options, minimum (in years) 2    
Expected life options, maximum (in years) 4    
Weighted-average fair value per share at grant date (in dollars per share) $ 18.24    
Stock Options, Shares [Roll Forward]      
Outstanding, beginning of period (in shares) 1,625,327    
Granted (in shares) 10,500 0  
Exercised (in shares) (30,182)    
Forfeited or expired (in shares) (15,791)    
Outstanding, end of period (in shares) 1,589,854    
Exercisable, end of period (in shares) 954,735    
Weighted-Average Exercise Price [Abstract]      
Outstanding, beginning of period (in dollars per share) $ 43.96    
Granted (in dollars per share) $ 62.26    
Exercised (in dollars per share) $ 36.63    
Forfeited or expired (in dollars per share) $ 57.64    
Outstanding, end of period (in dollars per share) $ 44.08    
Exercisable, end of period (in dollars per share) $ 38.54    
Weighted-Average Remaining Contractual Term [Abstract]      
Outstanding, end of period (in years) 7.1    
Exercisable, end of period (in years) 6.2    
Aggregate Intrinsic Value [Abstract]      
Outstanding, end of period 36,657,000    
Exercisable, end of period 27,340,000    
Unrecognized compensation expense 4,600,000    
Weighted-average period of cost recognition (in years) 1.83    
Intrinsic value of stock options exercised 900,000    
Stock Options [Member] | Granted to Directors [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration term (in years) P10Y    
Stock Options [Member] | Granted to Employees [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration term (in years) P10Y    
Restricted Stock Awards and Units [Member]
     
Compensation Expense [Abstract]      
Total stock-based compensation expense 871,000 288,000  
Aggregate Intrinsic Value [Abstract]      
Unrecognized compensation expense 4,300,000    
Weighted-average period of cost recognition (in years) 1.67    
Number of Awards [Abstract]      
Outstanding, beginning of period (in shares) 109,907    
Granted (in shares) 0    
Vested (in shares) 0    
Forfeited (in shares) 0    
Outstanding, end of period (in shares) 109,907    
Weighted-Average Grant Date Fair Value [Roll Forward]      
Outstanding, beginning of period (in dollars per share) $ 60.13    
Granted (in dollars per share) $ 0    
Vested (in dollars per share) $ 0    
Forfeited (in dollars per share) $ 0    
Outstanding, end of period (in dollars per share) $ 60.13    
Performance Shares [Member]
     
Compensation Expense [Abstract]      
Total stock-based compensation expense 490,000 0  
Aggregate Intrinsic Value [Abstract]      
Unrecognized compensation expense $ 2,900,000    
Weighted-average period of cost recognition (in years) 1.28    
Number of Awards [Abstract]      
Outstanding, beginning of period (in shares) 67,155   67,155
Granted (in shares) 0    
Forfeited (in shares) 0    
Outstanding, end of period (in shares)     67,155
Weighted-Average Grant Date Fair Value [Roll Forward]      
Outstanding, end of period (in dollars per share) $ 58.66